Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia
Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined... read more
January 4, 2023
Tagged: acute myeloid leukemia
Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer
Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more
October 19, 2022
Trending With Impact: New Pre-Transplant AML Treatment Combinations
Researchers aimed to improve acute myeloid leukemia (AML) patient outcomes after allo-HSCT with new pre-transplant... read more
February 17, 2022
New Study: Nanoparticles Target Acute Myeloid Leukemia
Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting... read more
September 15, 2021
Tomivosertib Versus Acute Myeloid Leukemia
In the cover paper chosen for Oncotarget’s Volume 12, Issue 10, researchers investigated the... read more
May 12, 2021
Trending with Impact: Acute Myeloid Leukemia and Midostaurin Response
Researchers examined midostaurin resistance and sensitivity in a cohort of patients with acute myeloid leukemia.... read more
April 22, 2021